WATCH THE LATEST FROM BIO 2026
Subscribe to Bio.News Weekly Newsletter
Get Bio.News in your inbox every Monday morning.
SubscribeNo spam. Just science. Unsubscribe at any time.
Latest News
BIO 2026: To restore trust in vaccines, listen to everyone’s concerns
Listening to people’s concerns about vaccines is key to helping them regain trust, according to experts promoting the need for...
BIO 2026: Realizing the promise of CAR-T cell therapies
“CAR-T cell therapies are remarkable drugs and are the gold standard for patients,” said Rachel Haurwitz, PhD, President & CEO...
FDA Advisory Committee to weigh whether to expand compounding of unapproved peptides
The FDA's Pharmacy Compounding Advisory Committee (PCAC) will consider this week whether seven unapproved peptides should be added to the...
BIO 2026: FDA leaders discuss restoring workforce, institutional knowledge
While the U.S. Food and Drug Administration (FDA) has faced significant change in recent years, industry leaders and agency officials...
BIO expresses concerns over proposed OMB rule to regulate federal grants
A new proposal to regulate federal grants risks destabilizing the system of government support essential to developing innovative therapies American...
BIO 2026: Industry PDUFA negotiators describe their agreement with FDA
Industry leaders at BIO 2026 discussed the proposed PDUFA VIII next steps. After a year of discussion with the industry...